{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:18:00Z","timestamp":1780618680554,"version":"3.54.1"},"reference-count":58,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The ability of the Veterans Health Administration System to care for veterans with bladder cancer is influenced by the increased complexity of both veterans and the system\u2019s capacity to do so, which is determined by personnel and equipment allocation. Herein, we review the guidelines for bladder cancer management in the context of this population and highlight unique veteran characteristics that impact the delivery of bladder cancer care within the Veterans Health Administration System. There are opportunities for standardization and implementation, which can improve the quality of this care, and we summarize the questions for which coordinated research efforts may provide answers.<\/jats:p>","DOI":"10.3390\/curroncol31110493","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:51:26Z","timestamp":1730109086000},"page":"6686-6698","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Management of Non-Muscle-Invasive Bladder Cancer in a Veteran Patient Population: Issues and Recommendations"],"prefix":"10.3390","volume":"31","author":[{"given":"Jennifer","family":"Taylor","sequence":"first","affiliation":[{"name":"Operative Care Line, Urology Section, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Patel","sequence":"additional","affiliation":[{"name":"Operative Care Line, Urology Section, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnanath","family":"Gaitonde","sequence":"additional","affiliation":[{"name":"Department of Urology, Cincinnati VA Medical Center, University of Cincinnati Cancer Institute, Cincinnati, OH 45220, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Greene","sequence":"additional","affiliation":[{"name":"San Francisco VA Health Care System, San Francisco, CA 94121, USA"},{"name":"Department of Urology, UCSF Medical Center, San Francisco, CA 94121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Liao","sequence":"additional","affiliation":[{"name":"VA Palo Alto Health Care System, Palo Alto, CA 94304, USA"},{"name":"Department of Urology, Stanford University School of Medicine, Palo Alto, CA 94304, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-3407","authenticated-orcid":false,"given":"Glen","family":"McWilliams","sequence":"additional","affiliation":[{"name":"James J. Peters Veterans Affairs Medical Center, Bronx, NY 10468, USA"},{"name":"Department of Urology, Mount Sinai School of Medicine, Bronx, NY 10468, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sawyer","sequence":"additional","affiliation":[{"name":"Rocky Mountain Regional VA Medical Center, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1860-2611","authenticated-orcid":false,"given":"Florian","family":"Schroeck","sequence":"additional","affiliation":[{"name":"White River Junction VA Medical Center, White River Junction, VT 05009, USA"},{"name":"Dartmouth Geisel School of Medicine, Hanover, NH 03755, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly","family":"Alrabaa","sequence":"additional","affiliation":[{"name":"College of Natural Sciences and Mathematics, University of Houston, Houston, TX 77004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3053-5828","authenticated-orcid":false,"given":"Gal","family":"Saffati","sequence":"additional","affiliation":[{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Kronstedt","sequence":"additional","affiliation":[{"name":"Operative Care Line, Urology Section, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-6832","authenticated-orcid":false,"given":"Jeffrey","family":"Jones","sequence":"additional","affiliation":[{"name":"Operative Care Line, Urology Section, Michael E DeBakey Veteran Affairs Medical Center, Houston, TX 77030, USA"},{"name":"Scott Department of Urology, Baylor College of Medicine, Houston, TX 77030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use","volume":"160","author":"Agha","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"ref_2","first-page":"13","article-title":"Current and Projected Characteristics and Unique Health Care Needs of the Patient Population Served by the Department of Veterans Affairs","volume":"5","author":"Eibner","year":"2016","journal-title":"Rand Health Q."},{"key":"ref_3","unstructured":"Institute of Medicine (US) Committee on the Initial Assessment of Readjustment Needs of Military Personnel, Veterans, and Their Families (2010). Returning Home from Iraq and Afghanistan: Preliminary Assessment of Readjustment Needs of Veterans, Service Members, and Their Families, National Academies Press (US)."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/BLC-230099","article-title":"Non-Muscle Invasive Bladder Cancer: Many More Patients Die With It Than Of It","volume":"10","author":"McGonagle","year":"2024","journal-title":"Bladder Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11606-009-1117-3","article-title":"Mental health diagnoses and utilization of VA non-mental health medical services among returning Iraq and Afghanistan veterans","volume":"25","author":"Cohen","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11606-009-1160-0","article-title":"Smoking Prevalence among US Veterans","volume":"25","author":"Brown","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e1883","DOI":"10.7205\/MILMED-D-16-00371","article-title":"Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update","volume":"182","author":"Zullig","year":"2017","journal-title":"Mil. Med."},{"key":"ref_8","unstructured":"National Academies of Sciences, Engineering, and Medicine (2016). Veterans and Agent Orange: Update 2014, National Academies Press (US)."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnci\/djm004","article-title":"Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water","volume":"99","author":"Marshall","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-069X-13-10","article-title":"Evaluation of mortality among marines and navy personnel exposed to contaminated drinking water at US MC base Camp Lejeune: A retrospective cohort study","volume":"13","author":"Bove","year":"2014","journal-title":"Environ. Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijsu.2015.04.079","article-title":"ASA class is a reliable independent predictor of medical complications and mortality following surgery","volume":"18","author":"Hackett","year":"2015","journal-title":"Int. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMsa021899","article-title":"Effect of the transformation of the Veterans Affairs Health Care System on the quality of care","volume":"348","author":"Jha","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rubio-Briones, J., Algaba, F., Gallardo, E., Marcos-Rodr\u00edguez, J.A., and Climent, M.\u00c1. (2021). Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group. Cancers, 13.","DOI":"10.3390\/cancers13194762"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.urology.2016.07.040","article-title":"Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?","volume":"98","author":"Schroeck","year":"2016","journal-title":"Urology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jso.21282","article-title":"Standardized synoptic cancer pathology reporting: A population-based approach","volume":"99","author":"Srigley","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e183442","DOI":"10.1001\/jamanetworkopen.2018.3442","article-title":"Extent of Risk-Aligned Surveillance for Cancer Recurrence Among Patients With Early-Stage Bladder Cancer","volume":"1","author":"Schroeck","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0090-4295(01)00919-0","article-title":"Evaluation of asymptomatic microscopic hematuria in adults: The American Urological Association best practice policy--part I: Definition, detection, prevalence, and etiology","volume":"57","author":"Grossfeld","year":"2001","journal-title":"Urology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU Guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J. Urol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plabm.2016.03.002","article-title":"The comparison of automated urine analyzers with manual microscopic examination for urinalysis automated urine analyzers and manual urinalysis","volume":"5","author":"Zengin","year":"2016","journal-title":"Pract. Lab. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/cncr.25048","article-title":"High-risk patients with hematuria are not evaluated according to guideline recommendations","volume":"116","author":"Elias","year":"2010","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.10.018","article-title":"Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey","volume":"28","author":"Nieder","year":"2010","journal-title":"Urol. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-5347(05)67916-5","article-title":"A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice","volume":"163","author":"Khadra","year":"2000","journal-title":"J. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Navarese, E.P., Gurbel, P.A., Andreotti, F., Ko\u0142odziejczak, M.M., Palmer, S.C., Dias, S., Buffon, A., Kubica, J., Kowalewski, M., and Jadczyk, T. (2017). Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168726"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.urology.2016.10.055","article-title":"Detection of Upper Tract Urothelial Malignancies by Computed Tomography Urography in Patients Referred for Hematuria at a Large Tertiary Referral Center","volume":"102","author":"Commander","year":"2017","journal-title":"Urology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/JU.0000000000002175","article-title":"Diagnostic and Cost Implications of the 2020 AUA Microhematuria Guidelines: Modeling Impact in a Large Public Health Care System","volume":"207","author":"Gold","year":"2022","journal-title":"J. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamainternmed.2017.0739","article-title":"Cost-effectiveness of Common Diagnostic Approaches for Evaluation of Asymptomatic Microscopic Hematuria","volume":"177","author":"Halpern","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5489\/cuaj.3143","article-title":"Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta","volume":"10","author":"Gotto","year":"2016","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.euf.2017.10.004","article-title":"Long-term Outcomes from Re-resection for High-risk Non-muscle-invasive Bladder Cancer: A Potential to Rationalize Use","volume":"5","author":"Gordon","year":"2019","journal-title":"Eur. Urol. Focus"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1001\/jama.2018.4657","article-title":"Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial","volume":"319","author":"Messing","year":"2018","journal-title":"JAMA"},{"key":"ref_32","first-page":"1471","article-title":"Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor","volume":"31","author":"Onishi","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.5489\/cuaj.5122","article-title":"Overnight continuous saline irrigation after transurethral resection for non-muscle-invasive bladder cancer is helpful in prevention of early recurrence","volume":"12","author":"Do","year":"2018","journal-title":"Can. Urol. Assoc. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","article-title":"Can intravesical bacillus Calmette-Gu\u00e9rin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials","volume":"67","author":"Han","year":"2006","journal-title":"Urology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.ju.0000062605.92268.c6","article-title":"Defining bacillus Calmette-Guerin refractory superficial bladder tumors","volume":"169","author":"Herr","year":"2003","journal-title":"J. Urol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J. Urol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): A systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int."},{"key":"ref_38","first-page":"CD009294","article-title":"Intravesical gemcitabine for non-muscle invasive bladder cancer","volume":"1","author":"Jones","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Prasanna, T., Craft, P., Balasingam, G., Haxhimolla, H., and Pranavan, G. (2017). Intravesical Gemcitabine versus Intravesical Bacillus Calmette-Gu\u00e9rin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00260"},{"key":"ref_40","unstructured":"(2022, April 10). BCG Shortage Info\u2014American Urological Association. n.d. Available online: https:\/\/www.auanet.org\/about-us\/bcg-shortage-info."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: Costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_42","first-page":"e413","article-title":"Mp29-03 cost implications of perioperative intravesical chemotherapy for bladder tumor resection: Gemcitabine versus mitomycin-c","volume":"201","author":"Bens","year":"2019","journal-title":"J. Urol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/bju.12012","article-title":"Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Gu\u00e9rin (BCG): Results of an international individual patient data survey (IPDS)","volume":"112","author":"Witjes","year":"2013","journal-title":"BJU Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urpr.2017.02.002","article-title":"Exploring Patterns of Mitomycin C Use in Community Practice Urology","volume":"5","author":"Mossanen","year":"2018","journal-title":"Urol. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J. Urol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.juro.2010.06.148","article-title":"Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer","volume":"184","author":"Stenzl","year":"2010","journal-title":"J. Urol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"E297-303","DOI":"10.1111\/j.1464-410X.2011.10090.x","article-title":"Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta\/T1 patients: A randomized two-centre study","volume":"108","author":"Hermann","year":"2011","journal-title":"BJU Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.ju.0000100480.70769.0e","article-title":"Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy","volume":"171","author":"Schmidbauer","year":"2004","journal-title":"J. Urol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.juro.2007.03.034","article-title":"A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer","volume":"178","author":"Grossman","year":"2007","journal-title":"J. Urol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.ju.0000169257.19841.2a","article-title":"Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study","volume":"174","author":"Jocham","year":"2005","journal-title":"J. Urol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.juro.2017.11.096","article-title":"Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study","volume":"199","author":"Daneshmand","year":"2018","journal-title":"J. Urol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur. Urol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.juro.2012.03.007","article-title":"Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy","volume":"188","author":"Grossman","year":"2012","journal-title":"J. Urol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3233\/BLC-160048","article-title":"The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer\u2014A New Analysis","volume":"2","author":"Kamat","year":"2016","journal-title":"Bladder Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"361.e1","DOI":"10.1016\/j.urolonc.2018.04.013","article-title":"Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry","volume":"36","author":"Daneshmand","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1464-410X.1990.tb14893.x","article-title":"Morbidity following cystoscopy: Comparison of flexible and rigid techniques","volume":"66","author":"Denholm","year":"1990","journal-title":"Br. J. Urol."},{"key":"ref_57","unstructured":"Karl Storz SE & Co. KG (2017). White Paper, OR1(TM) StreamConnect(R) II System, Karl Storz SE & Co. KG."},{"key":"ref_58","unstructured":"(2022, April 10). Urological Society for American Veterans. n.d. Available online: https:\/\/govurology.org\/usav\/."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/493\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:21:58Z","timestamp":1760113318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/31\/11\/493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["curroncol31110493"],"URL":"https:\/\/doi.org\/10.3390\/curroncol31110493","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]}}}